|
1
|
Lacy BE, Mearin F, Chang L, Chey WD, Lembo
AJ, Simren M and Spiller R: Bowel Disorders. Gastroenterology.
150:P1393–P1407.E5. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Black CJ and Ford AC: Global burden of
irritable bowel syndrome: Trends, predictions and risk factors. Nat
Rev Gastroenterol Hepatol. 17:473–486. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
El-Salhy M, Ostgaard H, Gundersen D,
Hatlebakk JG and Hausken T: The role of diet in the pathogenesis
and management of irritable bowel syndrome (review). Int J Mol Med.
29:723–731. 2012.PubMed/NCBI
|
|
4
|
Besterman HS, Sarson DL, Rambaud JC,
Stewart JS, Guerin S and Bloom SR: Gut hormone responses in the
irritable bowel syndrome. Digestion. 21:219–224. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Semnani S, Roshandel G, Keshtkar A, Najafi
L, Amiriani T, Farajollahi M, Moradi A and Joshaghani H: Serum
leptin levels and irritable bowel syndrome: A new hypothesis. J
Clin Gastroenterol. 43:826–830. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
El-Salhy M, Hatlebakk JG, Gilja OH and
Hausken T: Irritable bowel syndrome: Recent developments in
diagnosis, pathophysiology, and treatment. Expert Rev Gastroenterol
Hepatol. 8:435–443. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cummings DE and Overduin J:
Gastrointestinal regulation of food intake. J Clin Invest.
117:13–23. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wahren J, Ekberg K, Johansson J,
Henriksson M, Pramanik A, Johansson BL, Rigler R and Jörnvall H:
Role of C-peptide in human physiology. Am J Physiol Metab.
278:E759–E768. 2000.PubMed/NCBI
|
|
9
|
Drucker DJ: The role of gut hormones in
glucose homeostasis. J Clin Invest. 117:24–32. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Al-Suhaimi EA and Shehzad A: Leptin,
resistin and visfatin: The missing link between endocrine metabolic
disorders and immunity. Eur J Med Res. 18:122013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
El-Salhy M, Gilja OH, Gundersen D,
Hatlebakk JG and Hausken T: Interaction between ingested nutrients
and gut endocrine cells in patients with irritable bowel syndrome
(review). Int J Mol Med. 34:363–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
McKenzie YA, Bowyer RK, Leach H, Gulia P,
Horobin J, O'Sullivan NA, Pettitt C, Reeves LB, Seamark L, Williams
M, et al: British dietetic association systematic review and
evidence-based practice guidelines for the dietary management of
irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet.
29:549–575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Algera J, Colomier E and Simrén M: The
dietary management of patients with irritable bowel syndrome: A
narrative review of the existing and emerging evidence. Nutrients.
11:21622019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mitchell H, Porter J, Gibson PR, Barrett J
and Garg M: Review article: Implementation of a diet low in FODMAPs
for patients with irritable bowel syndrome-directions for future
research. Aliment Pharmacol Ther. 49:124–139. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nilholm C, Larsson E, Roth B, Gustafsson R
and Ohlsson B: Irregular dietary habits with a high intake of
cereals and sweets are associated with more severe gastrointestinal
symptoms in IBS patients. Nutrients. 11:12792019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nilholm C, Roth B and Ohlsson B: A dietary
intervention with reduction of starch and sucrose leads to reduced
gastrointestinal and extra-intestinal symptoms in IBS patients.
Nutrients. 11:16622019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nilholm C, Larsson E, Sonestedt E, Roth B
and Ohlsson B: Assessment of a 4-week starch- and sucrose-reduced
diet and its effects on gastrointestinal symptoms and inflammatory
parameters among patients with irritable bowel syndrome. Nutrients.
13:4162021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Saidi K, Nilholm C, Roth B and Ohlsson B:
A carbohydrate-restricted diet for patients with irritable bowel
syndrome lowers serum C-peptide, insulin, and leptin without any
correlation with symptom reduction. Nutr Res. 86:23–36. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rose DR, Chaudet MM and Jones K:
Structural studies of the intestinal α-glucosidases,
maltase-glucoamylase and sucrase-isomaltase. J Pediatr
Gastroenterol Nutr. 66 (Suppl 3):S11–S13. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Treem WR: Congenital sucrase-isomaltase
deficiency. J Pediatr Gastroenterol Nutr. 21:1–14. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gudmand-Høyer E, Fenger HJ, Kern-Hansen P
and Madsen PR: Sucrase deficiency in Greenland. Incidence and
genetic aspects. Scand J Gastroentreol. 22:24–28. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Treem WR: Clinical aspects and treatment
of congenital sucrase-isomaltase deficiency. J Pediatr
Gastroenterol Nutr. 55 (Suppl 2):S7–S13. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Garcia-Etxebarria K, Zheng T, Bonfiglio F,
Bujanda L, Dlugosz A, Lindberg G, Schmidt PT, Karling P, Ohlsson B,
Simren M, et al: Increased prevalence of rare sucrase-isomaltase
pathogenic variants in irritable bowel syndrome patients. Clin
Gastroenterol Hepatol. 16:1673–1676. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Henström M, Diekmann L, Bonfiglio F,
Hadizadeh F, Kuech EM, Von Köckritz-Blickwede M, Thingholm LB,
Zheng T, Assadi G, Dierks C, et al: Functional variants in the
sucrase-isomaltase gene associate with increased risk of irritable
bowel syndrome. Gut. 67:263–270. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tundis R, Loizzo MR and Menichini F:
Natural products as alpha-amylase and alpha-glucosidase inhibitors
and their hypoglycaemic potential in the treatment of diabetes: An
update. Mini Rev Med Chem. 10:315–331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim SB, Calmet FH, Garrido J,
Garcia-Buitrago MT and Moshiree B: Sucrase-isomaltase deficiency as
a potential masquerader in irritable bowel syndrome. Dig Dis Sci.
65:534–540. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gorboulev V, Schürmann A, Vallon V, Kipp
H, Jaschke A, Klessen D, Friedrich A, Scherneck S, Rieg T, Cunard
R, et al: Na(+)-D-glucose cotransporter SGLT1 is pivotal for
intestinal glucose absorption and glucose-dependent incretin
secretion. Diabetes. 61:187–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koepsell H: Glucose transporters in the
small intestine in health and disease. Pflugers Arch.
472:1207–1248. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smith MW, Peacock MA and James PS:
Galactose increases microvillus development in mouse jejunal
enterocytes. Comp Biochem Physiol A Comp Physiol. 100:489–493.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lorenz-Meyer H, Thiel F, Menge H,
Gottesbüren H and Riecken EO: Structural and functional studies on
the transformation of the intestinal mucosa in rats with
experimental diabetes. Res Exp Med (Berl). 170:89–99. 1977.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stevenson NR, Ferrigni F, Parnicky K, Day
S and Fierstein JS: Effect of changes in feeding schedule on the
diurnal rhythms and daily activity levels of intestinal brush
border enzymes and transport systems. Biochim Biophys Acta.
406:131–145. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Iwashina I, Mochizuki K, Inamochi Y and
Goda T: Clock genes regulate the feeding schedule-dependent diurnal
rhythm changes in hexose transporter gene expressions through the
binding of BMAL1 to the promoter/enhancer and transcribed regions.
J Nutr Biochem. 22:334–343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hara E and Saito M: Diurnal change in
digestion and absorption of sucrose in vivo in rats. J Nutr Sci
Vitaminol (Tokyo). 35:667–671. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Miyamoto K, Hase K, Takagi T, Fujii T,
Taketani Y, Minami H, Oka T and Nakabou Y: Differential responses
of intestinal glucose transporter mRNA transcripts to levels of
dietary sugars. Biochem J. 295:211–215. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Margolskee RF, Dyer J, Kokrashvili Z,
Salmon KS, Ilegems E, Daly K, Maillet EL, Ninomiya Y, Mosinger B
and Shirazi-Beechey SP: T1R3 and gustducin in gut sense sugars to
regulate expression of Na+-glucose cotransporter 1. Proc
Natl Acad Sci USA. 104:15075–15080. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pereira DF, Cazarolli LH, Lavado C,
Mengatto V, Figueiredo MS, Guedes A, Pizzolatti MG and Silva FR:
Effects of flavonoids on α-glucosidase activity: Potential targets
for glucose homeostasis. Nutrition. 27:1161–1167. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lindquist B and Meeuwisse GW: Chronic
diarrhoea caused by monosaccharide malabsorption. Acta Paediatr.
51:674–685. 1962. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang J, Cortina G, Wu SV, Tran R, Cho JH,
Tsai MJ, Bailey TJ, Jamrich M, Ament ME, Treem WR, et al: Mutant
neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med.
355:270–280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Santer R, Schneppenheim R, Suter D, Schaub
J and Steinmann B: Fanconi-Bickel syndrome-the original patient and
his natural history, historical steps leading to the primary
defect, and a review of the literature. Eur J Pediatr. 157:783–797.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsan L, Décarie-Spain L, Noble EE and
Kanoski SE: Western diet consumption during development: setting
the stage for neurocognitive dysfunction. Front Neurosci.
15:6323122021. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Douard V and Ferraris RP: Regulation of
the fructose transporter GLUT5 in health and disease. Am J Physiol
Endocrinol Metab. 295:E227–E237. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Skoog SM and Bharucha AE: Dietary fructose
and gastrointestinal symptoms: A review. Am J Gastroenterol.
99:2046–2050. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wasserman D, Hoekstra JH, Tolia V, Taylor
CJ, Kirschner BS, Takeda J, Bell GI, Taub R and Rand EB: Molecular
analysis of the fructose transporter gene (GLUT5) in isolated
fructose malabsorption. J Clin Invest. 98:2398–2402. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu LC, Turner JR and Buret AG: LPS/CD14
activation triggers SGLT-1-mediated glucose uptake and cell rescue
in intestinal epithelial cells via early apoptotic signals upstream
of caspase-3. Exp Cell Res. 312:3276–3286. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ikari A, Nagatani Y, Tsukimoto M, Harada
H, Miwa M and Takagi K: Sodium-dependent glucose transporter
reduces peroxynitrite and cell injury caused by cisplatin in renal
tubular epithelial cells. Biochim Biophys Acta. 1717:109–117. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Vincent AM, Hayes JM, McLean LL,
Vivekanandan-Giri A, Pennathur S and Feldman EL:
Dyslipidemia-induced neuropathy in mice: The role of oxLDL/LOX-1.
Diabetes. 58:2376–2385. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kim B and Feldman EL: Insulin resistance
in the nervous system. Trends Endocrinol Metabol. 23:133–141. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Callaghan B and Feldman E: The metabolic
syndrome and neuropathy: Therapeutic challenges and opportunities.
Ann Neurol. 74:397–403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Preguiça I, Alves A, Nunes S, Gomes P,
Fernandes R, Viana SD and Reis F: Diet-induced rodent models of
diabetic peripheral neuropathy, retinopathy and nephropathy.
Nutrients. 12:2502020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pranprawit A, Wolber FM, Heyes JA, Molan
AL and Kruger MC: Short-term and long-term effects of excessive
consumption of saturated fats and/or sucrose on metabolic variables
in sprague dawley rats: A pilot study. J Sci Food Agric.
93:3191–3197. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xie F, Fu H, Hou JF, Jiao K, Costigan M
and Chen J: High energy diets-induced metabolic and prediabetic
painful polyneuropathy in rats. PLoS One. 8:e574272013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Smith AG, Rose K and Singleton JR:
Idiopathic neuropathy patients are at high risk for metabolic
syndrome. J Neurol Sci. 273:25–28. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Calcutt NA, Cooper ME, Kern TS and Schmidt
AM: Therapies for hyperglycaemia-induced diabetic complications:
From animal models to clinical trials. Nat Rev Drug Discov.
8:417–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Smith AG: Impaired glucose tolerance and
metabolic syndrome in idiopathic neuropathy. J Peripher Nerv Syst.
17 (Suppl 2):S15–S21. 2012. View Article : Google Scholar
|
|
55
|
Hossain MJ, Kendig MD, Wild BM, Issar T,
Krishnan AV, Morris MJ and Arnold R: Evidence of altered peripheral
nerve function in a rodent model of diet-induced prediabetes.
Biomedicines. 8:3132020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bostock H, Cirkurel K and Burke D:
Threshold tracking techniques in the study of human peripheral
nerve. Muscle Nerve. 21:137–158. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lin YC, Lin CS, Chang TS, Lee JE, Tani J,
Chen HJ and Sung JY: Early sensory neurophysiological changes in
prediabetes. J Diabetes Investig. 11:458–465. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Sung JY, Tani J, Chang TS and Lin CS:
Uncovering sensory axonal dysfunction in asymptomatic type 2
diabetic neuropathy. PLoS One. 12:e1712232017. View Article : Google Scholar
|
|
59
|
Callaghan BC, Cheng HT, Stables CL, Smith
SL and Feldman EL: Diabetic neuropathy: Clinical manifestations and
current treatments. Lancet Neurol. 11:521–534. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ramne S, Drake I, Ericson U, Nilsson J,
Orho-Melander M, Engström G and Sonestedt E: Identification of
inflammatory and disease-associated plasma proteins that associate
with intake of added sugar and sugar-sweetened beverages and their
role in type 2 diabetes risk. Nutrients. 12:31292020. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Darwiche G, Höglund P, Roth B, Larsson E,
Sjöberg T, Wohlfart B, Steen S and Ohlsson B: An okinawan-based
nordic diet improves anthropometry, metabolic control, and
health-related quality of life in scandinavian patients with type 2
diabetes: A pilot trial. Food Nutr Res. 60:325942016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Della Corte KW, Perrar I, Penczynski KJ,
Schwingshackl L, Herder C and Buyken AE: Effect of dietary sugar
intake on biomarkers of subclinical inflammation: A systematic
review and meta-analysis of intervention studies. Nutrients.
10:6062018. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Eriksson EM, Andrén KI, Eriksson HT and
Kurlberg GK: Irritable bowel syndrome subtypes differ in body
awareness, psychological symptoms and biochemical stress markers.
World J Gastroenterol. 14:4889–4896. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Mazur M, Furgała A, Jabłoński K, Mach T
and Thor P: Autonomic nervous system activity in
constipation-predominant irritable bowel syndrome patients. Med Sci
Monit. 18:CR493–CR499. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Gulcan E, Taser F, Toker A, Korkmaz U and
Alcelik A: Increased frequency of prediabetes in patients with
irritable bowel syndrome. Am J Med Sci. 338:116–119. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Roberts CK, Hevener AL and Barnard RJ:
Metabolic syndrome and insulin resistance: Underlying causes and
modification by exercise training. Compr Physiol. 3:1–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Camilleri M and Boeckxstaens G: Dietary
and pharmacological treatment of abdominal pain in IBS. Gut.
66:966–974. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Grundy SM, Cleeman JI, Daniels SR, Donato
KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith
SC Jr, et al: Diagnosis and management of the metabolic syndrome:
An American heart association/national heart, lung, and blood
institute scientific statement. Circulation. 112:2735–2752. 2005.
View Article : Google Scholar : PubMed/NCBI
|
